Impact of comorbidity and harmful habits on treatment success in patients with laryngeal cancer
Abstract
Background: Survival of the patients with head and neck cancer is affected by the tumor stage and also by comorbidity. The aim of the study was to evaluate the impact of comorbidity (respiratory, cardiovascular, gastrointestinal, neurological and systemic diseases) and harmful habits on treatment results of laryngeal cancer.
Methods: Eighty-nine patients with squamous cell carcinoma of the larynx (92 % men) who had been surgically treated at the University Department of Otorhinolaryngology and Cervicofacial Surgery in Ljubljana between January 1, 1996 and December 31, 1998 have been included into the retrospective study. Most of the patients were treated with radiotherapy or chemotherapy for the same cancer at the Institute of Oncology in Ljubljana. The medical data were obtained from medical hospital records, the data of Slovene Registry of Cancer and the Slovene Institute for Health Care.
Results: The mean age of the patients was 59.5 years. There were only 4 % of non-smokers in the studied population. In 33 % of patients excessive consumption of alcohol was documented. In 84 % of all patients at least one comorbidity was detected. Fifty-four percent of them had pulmonary, 39 % cardiovascular, 26 % systemic, 25 % gastrointestinal, and 3 % neurological diseases. Significantly shorter 5-year survival was found in patients with an advanced tumour (p = 0.002 ÷2), neck metastases (p = 0.000 ÷2), and advanced age (0.042 ÷2). The results of the study presented a significant impact of alcohol consumption on survival of our patients (p = 0.014 ÷2). The comorbidity was detected more often in patients with excessive alcohol consumption (p = 0.046 ÷2) and in older patients (0.018 ÷2). The anaesthesiologist’s assessment of the patients’ health status also influenced their 5-year survival (p = 0.014 [Fisher exact]).
Conclusions: Comorbidity, which can be a result of harmful habits, is very often found in laryngeal cancer patients. A significantly shorter survival was connected with advanced tumour stage, advanced age, worse anaesthesiologist’s assessment before surgery and excessive alcohol consumption. No significant direct impact of comorbidity on survival was detected. The influence of comorbidity on the patients’ survival could be indirect because more comorbidities were found in older patients and in those with excessive alcohol intake. The comorbidity also influenced the anaesthesiologist’s assessment of the patients’ health status.
Downloads
References
Pompe-Kirn V. Incidenca raka ustne votline, orofarinksa in hipofarinksa ter grla v Sloveniji močno narašča. Zdrav Vestn 1992; 61: 193–6.
Incidenca raka v Sloveniji 2000. Ljubljana: Onkološki inštitut, Register raka za Slovenijo; 2003.
Paleri V, Wight RG. Applicability of the adult comorbidity evaluation – 27 and the Carlson indexes to assess comorbidity by notes extraction in a cohort of United Kingdom patients with head and neck cancer: a retrospective study. J Laryngol Otol 2002; 116: 200–5.
Hathaway B, Johnson JT, Piccirillo JF, Snyderman CH, Wagner RL, Labriola S, et al. Chemoradiation for metastatic SCCA: role of comorbidity. Laryngoscope 2001; 111: 1893–5.
Derks W, de Leeuw JR, Hordijk GJ, Winnubst JA. Reasons for non-standard treatment in elderly patients with advanced head and neck cancer. Eur Arch Otorhinolaryngol 2005; 262: 21–6.
Derks W, de Leeuw RJ, Hordijk GJ. Elderly patients with head and neck cancer: the influence of comorbidity on choice of therapy, complication rate, and survival. Curr Opin Otolaryngol Head Neck Surg 2005; 13: 92–6.
Ferrier MB, Spusens EB, Le Cessie S, Battenburg de Jong RJ. Comorbidity as a major risk factor for mortality and complications in head and neck surgery. Arch Otorhinolaryngol Head Neck Surg 2005; 131: 27–32.
Kaplan MH, Feinstein AR. The importance of classifying initial comorbidity in evaluating the outcome of diabetes mellitus. J Chron Dis 1974; 27: 387–404.
Piccirillo JF, Costas I. The impact of comorbidity on outcomes. ORL J Otorhinolaryngol Relat Spec 2004; 66: 180–5.
Sobin LH, Wittekind C. TNM classification of malignant tumours. 6th Edition. New York: Wiley-Liss; 2002.
Piccirillo JF. Inclusion of comorbidity in a staging system for head and neck cancer. Oncology 1995; 9: 831–6.
Lacy PD, Piccirillo JF, Merrit MG, Zequeira MR. Head and neck squamous cell carcinoma: better to be young. Otolaryngol Head Neck Surg 2000; 122: 253–8.
Singh B, Bhaya M, Zimbler M, Stern J, Roland JT, Rosenfeld RM, et al. Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma. Head Neck 1998; 20: 1–7.
Hall SF, Groome PA, Rothwell D. The impact of comorbidity on the survival of patients with squamous cell carcinoma of the head and neck. Head Neck 2000; 22: 317–22.
Piccirillo JF, Lacy PD, Basu A, Spitznagel EL. Development of a new head and neck cancer-specific comorbidity index. Arch Otolaryngol Head Neck Surg 2002; 128: 1172–9.
Paleri V, Narayan R, Wight RG. Descriptive study of the type and severity of decompensation caused by comorbidity in a population of patients with laryngeal squamous cancer. J Laryngol 2004; 118: 517–21.
Feinstein AR, Schimpff CR, Andrews JF, Wells CK. Cancer of the larynx: a new staging system and a reappraisal of prognosis and treatment. J Chron Dis 1988; 30: 277–305.
Chen AY, Matson LK, Roberts D, Goepfert H. The significance of comorbidity in advanced laryngeal cancer. Head Neck 2001; 23: 566–72.
Paleri V, Wight RG, Davies GR. Impact of comorbidity on the outcome of laryngeal squamous cancer. Head Neck 2003; 25: 1019–26.
Pompe-Kirn V, Primic-Žakelj M, Ferligoj A, Škrk J. Zemljevidi incidence raka v Sloveniji 1978–1987. Ljubljana: Onkološki inštitut; 1992. p 46–8.
Mahkovic-Hergouth K. Priprava onkološkega bolnika na operativni poseg v anesteziji. Onkologija 2001; 5(2): 67–71.
Guralnik JM. Assessing the impact of comorbidity in the older population. Ann Epidemiol 1996; 6: 376–80.
Deleyiannis FW, Thomas DB, Vaughan TL, Davis S. Alcoholism: independent predictor of survival in patients with head and neck cancer. J Natl Cancer Inst 1996; 88: 542–9.
Kowalski LP, Franco EL, De Andrade Sobrinho J, Oliveira BV, Pontes PL. Prognostic factors in laryngeal cancer patients submitted to surgical treatment. J Surg Oncol 1991; 48: 87–95.
Haynes SR, Lawler PG. An assessment of the consistency of ASA physical status classification alocation. Anaesthesia 1995; 50: 195–9.
Ferlito A, Harrison DF, Bailey BJ, Desanto LW. Are clinical classifications for laryngeal cancer satisfactory? Ann Otol Rhinol Laryngol 1995; 104: 741–7.
Sabin SL, Rosenfeld RM, Sundaram K, Har-El G, Lucente FE. The impact of comorbidity and age on survival with laryngeal cancer. Ear Nose Throat J 1999; 78: 581–4.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
